Sinicrope FA - Search Results

1

Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance).

Sinicrope FA, Mahoney MR, Yoon HH, Smyrk TC, Thibodeau SN, Goldberg RM, Nelson GD, Sargent DJ, Alberts SR; Alliance for Clinical Trials in Oncology. Sinicrope FA, et al. Clin Cancer Res. 2015 Dec 1;21(23):5294-304. doi: 10.1158/1078-0432.CCR-15-0527. Epub 2015 Jul 17. Clin Cancer Res. 2015. PMID: 26187617 Free PMC article.

2

Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma.

Sinicrope FA, Hart J, Michelassi F, Lee JJ. Sinicrope FA, et al. Clin Cancer Res. 1995 Oct;1(10):1103-10. Clin Cancer Res. 1995. PMID: 9815900

3

Phase I trial of sulindac plus 5-fluorouracil and levamisole: potential adjuvant therapy for colon carcinoma.

Sinicrope FA, Pazdur R, Levin B. Sinicrope FA, et al. Clin Cancer Res. 1996 Jan;2(1):37-41. Clin Cancer Res. 1996. PMID: 9816087 Clinical Trial.

4

bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome.

Sinicrope FA, Evans DB, Leach SD, Cleary KR, Fenoglio CJ, Lee JJ, Abbruzzese JL. Sinicrope FA, et al. Clin Cancer Res. 1996 Dec;2(12):2015-22. Clin Cancer Res. 1996. PMID: 9816161

5

Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.

Sinicrope FA, Hart J, Hsu HA, Lemoine M, Michelassi F, Stephens LC. Sinicrope FA, et al. Clin Cancer Res. 1999 Jul;5(7):1793-804. Clin Cancer Res. 1999. PMID: 10430084

6

Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis is inhibited by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human colon cancer cells.

Sinicrope FA, Penington RC, Tang XM. Sinicrope FA, et al. Clin Cancer Res. 2004 Dec 15;10(24):8284-92. doi: 10.1158/1078-0432.CCR-04-1289. Clin Cancer Res. 2004. PMID: 15623604

7

N0147: a randomized phase III trial of oxaliplatin plus 5-fluorouracil/leucovorin with or without cetuximab after curative resection of stage III colon cancer.

Alberts SR, Sinicrope FA, Grothey A. Alberts SR, et al. Among authors: sinicrope fa. Clin Colorectal Cancer. 2005 Sep;5(3):211-3. doi: 10.3816/ccc.2005.n.033. Clin Colorectal Cancer. 2005. PMID: 16197625 Clinical Trial. No abstract available.

8

Thymidylate synthase expression in colon carcinomas with microsatellite instability.

Sinicrope FA, Rego RL, Halling KC, Foster NR, Sargent DJ, La Plant B, French AJ, Allegra CJ, Laurie JA, Goldberg RM, Witzig TE, Thibodeau SN. Sinicrope FA, et al. Clin Cancer Res. 2006 May 1;12(9):2738-44. doi: 10.1158/1078-0432.CCR-06-0178. Clin Cancer Res. 2006. PMID: 16675565

9

Advances in chemotherapy for colorectal cancer.

Bernold DM, Sinicrope FA. Bernold DM, et al. Among authors: sinicrope fa. Clin Gastroenterol Hepatol. 2006 Jul;4(7):808-21. doi: 10.1016/j.cgh.2006.04.016. Epub 2006 Jun 22. Clin Gastroenterol Hepatol. 2006. PMID: 16797250 Review.

10

Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients.

Sinicrope FA, Rego RL, Halling KC, Foster N, Sargent DJ, La Plant B, French AJ, Laurie JA, Goldberg RM, Thibodeau SN, Witzig TE. Sinicrope FA, et al. Gastroenterology. 2006 Sep;131(3):729-37. doi: 10.1053/j.gastro.2006.06.005. Gastroenterology. 2006. PMID: 16952542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page